CA2901460A1 - Characterization of molecules in nanofluidics - Google Patents
Characterization of molecules in nanofluidics Download PDFInfo
- Publication number
- CA2901460A1 CA2901460A1 CA2901460A CA2901460A CA2901460A1 CA 2901460 A1 CA2901460 A1 CA 2901460A1 CA 2901460 A CA2901460 A CA 2901460A CA 2901460 A CA2901460 A CA 2901460A CA 2901460 A1 CA2901460 A1 CA 2901460A1
- Authority
- CA
- Canada
- Prior art keywords
- sample
- label
- molecules
- molecule
- labeling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000012512 characterization method Methods 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 164
- 210000004369 blood Anatomy 0.000 claims abstract description 32
- 239000008280 blood Substances 0.000 claims abstract description 32
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 18
- 108020004414 DNA Proteins 0.000 claims description 128
- 239000012634 fragment Substances 0.000 claims description 111
- 238000002372 labelling Methods 0.000 claims description 79
- 125000003729 nucleotide group Chemical group 0.000 claims description 53
- 239000002773 nucleotide Substances 0.000 claims description 52
- 102000053602 DNA Human genes 0.000 claims description 46
- 102000039446 nucleic acids Human genes 0.000 claims description 44
- 108020004707 nucleic acids Proteins 0.000 claims description 44
- 150000007523 nucleic acids Chemical class 0.000 claims description 44
- 239000002090 nanochannel Substances 0.000 claims description 36
- 210000000349 chromosome Anatomy 0.000 claims description 35
- 230000005856 abnormality Effects 0.000 claims description 34
- 230000003287 optical effect Effects 0.000 claims description 31
- 230000002068 genetic effect Effects 0.000 claims description 28
- 230000008774 maternal effect Effects 0.000 claims description 28
- 102000040430 polynucleotide Human genes 0.000 claims description 27
- 108091033319 polynucleotide Proteins 0.000 claims description 27
- 239000002157 polynucleotide Substances 0.000 claims description 27
- 230000001605 fetal effect Effects 0.000 claims description 22
- 102000016397 Methyltransferase Human genes 0.000 claims description 20
- 108060004795 Methyltransferase Proteins 0.000 claims description 20
- 230000005291 magnetic effect Effects 0.000 claims description 19
- 208000036878 aneuploidy Diseases 0.000 claims description 17
- 210000004027 cell Anatomy 0.000 claims description 17
- 231100001075 aneuploidy Toxicity 0.000 claims description 16
- 210000001519 tissue Anatomy 0.000 claims description 16
- 210000003917 human chromosome Anatomy 0.000 claims description 15
- 230000002285 radioactive effect Effects 0.000 claims description 15
- 239000007850 fluorescent dye Substances 0.000 claims description 14
- 208000037280 Trisomy Diseases 0.000 claims description 13
- 238000009826 distribution Methods 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 13
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 11
- 238000007689 inspection Methods 0.000 claims description 11
- 239000012530 fluid Substances 0.000 claims description 10
- 230000005945 translocation Effects 0.000 claims description 10
- 230000003321 amplification Effects 0.000 claims description 9
- 201000011510 cancer Diseases 0.000 claims description 9
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 9
- 230000002159 abnormal effect Effects 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 210000003765 sex chromosome Anatomy 0.000 claims description 8
- 210000002845 virion Anatomy 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 201000010374 Down Syndrome Diseases 0.000 claims description 7
- 101710147059 Nicking endonuclease Proteins 0.000 claims description 7
- 208000030454 monosomy Diseases 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 7
- 108091008146 restriction endonucleases Proteins 0.000 claims description 7
- 108091034117 Oligonucleotide Proteins 0.000 claims description 6
- 206010044688 Trisomy 21 Diseases 0.000 claims description 6
- 210000001124 body fluid Anatomy 0.000 claims description 6
- 239000010839 body fluid Substances 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 claims description 5
- 102000052510 DNA-Binding Proteins Human genes 0.000 claims description 5
- 230000004568 DNA-binding Effects 0.000 claims description 5
- 101710096438 DNA-binding protein Proteins 0.000 claims description 5
- 108091093037 Peptide nucleic acid Proteins 0.000 claims description 5
- 239000004952 Polyamide Substances 0.000 claims description 5
- 108091023040 Transcription factor Proteins 0.000 claims description 5
- 102000040945 Transcription factor Human genes 0.000 claims description 5
- 101710185494 Zinc finger protein Proteins 0.000 claims description 5
- 102100023597 Zinc finger protein 816 Human genes 0.000 claims description 5
- 230000005684 electric field Effects 0.000 claims description 5
- 150000004676 glycans Chemical class 0.000 claims description 5
- 230000005499 meniscus Effects 0.000 claims description 5
- 244000005700 microbiome Species 0.000 claims description 5
- 229920002647 polyamide Polymers 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 201000006360 Edwards syndrome Diseases 0.000 claims description 4
- 201000009928 Patau syndrome Diseases 0.000 claims description 4
- 208000020584 Polyploidy Diseases 0.000 claims description 4
- 208000035199 Tetraploidy Diseases 0.000 claims description 4
- 208000026487 Triploidy Diseases 0.000 claims description 4
- 206010044686 Trisomy 13 Diseases 0.000 claims description 4
- 208000006284 Trisomy 13 Syndrome Diseases 0.000 claims description 4
- 206010071762 Trisomy 14 Diseases 0.000 claims description 4
- 206010062757 Trisomy 15 Diseases 0.000 claims description 4
- 208000007159 Trisomy 18 Syndrome Diseases 0.000 claims description 4
- 239000012190 activator Substances 0.000 claims description 4
- 208000037516 chromosome inversion disease Diseases 0.000 claims description 4
- 230000002596 correlated effect Effects 0.000 claims description 4
- 208000027223 tetraploidy syndrome Diseases 0.000 claims description 4
- 238000013518 transcription Methods 0.000 claims description 4
- 230000035897 transcription Effects 0.000 claims description 4
- 230000002103 transcriptional effect Effects 0.000 claims description 4
- 206010053884 trisomy 18 Diseases 0.000 claims description 4
- 206010044689 trisomy 22 Diseases 0.000 claims description 4
- 208000031404 Chromosome Aberrations Diseases 0.000 claims description 3
- 210000003754 fetus Anatomy 0.000 abstract description 3
- 239000000523 sample Substances 0.000 description 239
- 239000002245 particle Substances 0.000 description 19
- 238000001514 detection method Methods 0.000 description 14
- 239000013074 reference sample Substances 0.000 description 12
- 230000000875 corresponding effect Effects 0.000 description 11
- 239000011324 bead Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- 210000004881 tumor cell Anatomy 0.000 description 8
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 7
- 230000002441 reversible effect Effects 0.000 description 7
- 238000004891 communication Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000002096 quantum dot Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 229930024421 Adenine Natural products 0.000 description 4
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 4
- 229960000643 adenine Drugs 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- -1 short DNA fragments Chemical class 0.000 description 4
- 108090001008 Avidin Proteins 0.000 description 3
- 238000001574 biopsy Methods 0.000 description 3
- 230000002759 chromosomal effect Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 239000000412 dendrimer Substances 0.000 description 3
- 229920000736 dendritic polymer Polymers 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 239000002070 nanowire Substances 0.000 description 3
- 150000004713 phosphodiesters Chemical class 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 108010068698 spleen exonuclease Proteins 0.000 description 3
- 101000969085 Geobacillus stearothermophilus Type II methyltransferase M.BseCI Proteins 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 108010087904 neutravidin Proteins 0.000 description 2
- 230000005298 paramagnetic effect Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 125000006853 reporter group Chemical group 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000001138 tear Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 206010008805 Chromosomal abnormalities Diseases 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 1
- 238000004435 EPR spectroscopy Methods 0.000 description 1
- 102000004150 Flap endonucleases Human genes 0.000 description 1
- 108090000652 Flap endonucleases Proteins 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102000055027 Protein Methyltransferases Human genes 0.000 description 1
- 108700040121 Protein Methyltransferases Proteins 0.000 description 1
- 208000037492 Sex Chromosome Aberrations Diseases 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108010073062 Transcription Activator-Like Effectors Proteins 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003322 aneuploid effect Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 102000023732 binding proteins Human genes 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 229920005605 branched copolymer Polymers 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000002230 centromere Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000000126 in silico method Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 229940046166 oligodeoxynucleotide Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000009598 prenatal testing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000004054 semiconductor nanocrystal Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Chemical group [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 102000055501 telomere Human genes 0.000 description 1
- 108091035539 telomere Proteins 0.000 description 1
- 210000003411 telomere Anatomy 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B30/10—Sequence alignment; Homology search
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/10—Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Physiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Clinical Laboratory Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361767219P | 2013-02-20 | 2013-02-20 | |
| US61/767,219 | 2013-02-20 | ||
| PCT/US2014/017226 WO2014130589A1 (en) | 2013-02-20 | 2014-02-19 | Characterization of molecules in nanofluidics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2901460A1 true CA2901460A1 (en) | 2014-08-28 |
Family
ID=51391777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2901460A Pending CA2901460A1 (en) | 2013-02-20 | 2014-02-19 | Characterization of molecules in nanofluidics |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US9809855B2 (enExample) |
| EP (1) | EP2959015B1 (enExample) |
| JP (2) | JP6542676B2 (enExample) |
| CN (1) | CN105229168B (enExample) |
| AU (1) | AU2014219001A1 (enExample) |
| CA (1) | CA2901460A1 (enExample) |
| WO (1) | WO2014130589A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10844424B2 (en) | 2013-02-20 | 2020-11-24 | Bionano Genomics, Inc. | Reduction of bias in genomic coverage measurements |
| CN105229168B (zh) | 2013-02-20 | 2020-07-17 | 生物纳米基因有限公司 | 纳米流体中分子的表征 |
| CN106164295B (zh) | 2014-02-25 | 2020-08-11 | 生物纳米基因公司 | 减小基因组覆盖测量中的偏差 |
| WO2018148903A1 (zh) * | 2017-02-16 | 2018-08-23 | 上海亿康医学检验所有限公司 | 泌尿系统肿瘤的辅助诊断方法 |
| DE102019200929A1 (de) * | 2019-01-25 | 2020-07-30 | Robert Bosch Gmbh | Verfahren und Vorrichtung zum optischen Erfassen einer Länge eines Makromoleküls |
| JP2023554621A (ja) * | 2020-12-15 | 2023-12-28 | クアンタム－エスアイ インコーポレイテッド | 超高感度バイオセンサ法 |
| WO2024145268A2 (en) | 2022-12-25 | 2024-07-04 | Bionano Genomics, Inc. | Optical genome mapping cartridges |
| EP4639178A1 (en) | 2022-12-25 | 2025-10-29 | Bionano Genomics, Inc. | Optical genome mapping system |
| EP4639177A1 (en) | 2022-12-25 | 2025-10-29 | Bionano Genomics, Inc. | Instrumentation of optical genome mapping systems |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030104428A1 (en) | 2001-06-21 | 2003-06-05 | President And Fellows Of Harvard College | Method for characterization of nucleic acid molecules |
| SG169225A1 (en) * | 2001-07-25 | 2011-03-30 | Univ Princeton | Nanochannel arrays and their preparation and use for high throughput macromolecular analysis |
| AU2003243691A1 (en) | 2002-06-20 | 2004-01-06 | Primera Biosystems, Inc. | Apparatus for polynucleotide detection and quantitation |
| US8346482B2 (en) * | 2003-08-22 | 2013-01-01 | Fernandez Dennis S | Integrated biosensor and simulation system for diagnosis and therapy |
| US20100216153A1 (en) * | 2004-02-27 | 2010-08-26 | Helicos Biosciences Corporation | Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities |
| US20060063184A1 (en) | 2004-09-09 | 2006-03-23 | Felix Carolyn A | Compositions and methods for the detection of DNA topoisomerase II complexes with DNA |
| JP2009529887A (ja) * | 2006-03-13 | 2009-08-27 | イコニシス インコーポレーテッド | 胎児細胞およびガン細胞を診断する非侵襲的方法 |
| EP3978121A1 (en) | 2006-07-19 | 2022-04-06 | BioNano Genomics, Inc. | Nanonozzle device arrays: their preparation and use for macromolecular analysis |
| US8722327B2 (en) * | 2007-03-28 | 2014-05-13 | Bionano Genomics, Inc. | Methods of macromolecular analysis using nanochannel arrays |
| EP3892736A1 (en) * | 2007-07-23 | 2021-10-13 | The Chinese University of Hong Kong | Determining a nucleic acid sequence imbalance |
| US20090076345A1 (en) | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Adherent Device with Multiple Physiological Sensors |
| JP4831236B2 (ja) | 2007-11-12 | 2011-12-07 | 株式会社村田製作所 | 操作位置検出器およびその応用装置 |
| KR20110016479A (ko) | 2008-06-06 | 2011-02-17 | 바이오나노매트릭스, 인크. | 통합 나노유체 분석 장치, 제작 방법 및 분석 기술 |
| US8628919B2 (en) * | 2008-06-30 | 2014-01-14 | Bionano Genomics, Inc. | Methods and devices for single-molecule whole genome analysis |
| WO2011050147A1 (en) | 2009-10-21 | 2011-04-28 | Bionanomatrix, Inc . | Methods and related devices for single molecule whole genome analysis |
| JP5846703B2 (ja) | 2008-11-18 | 2016-01-20 | バイオナノ ジェノミックス、インク． | ポリヌクレオチドのマッピング及び配列決定 |
| US20100137154A1 (en) * | 2008-12-01 | 2010-06-03 | Ach Robert A | Genome analysis using a methyltransferase |
| US20120097835A1 (en) | 2009-05-19 | 2012-04-26 | BioNano Geneomics, Inc. | Devices and methods for dynamic determination of sample position and orientation and dynamic repositioning |
| US9725315B2 (en) | 2009-09-28 | 2017-08-08 | Bionano Genomics, Inc. | Nanochannel arrays and near-field illumination devices for polymer analysis and related methods |
| SG189778A1 (en) * | 2009-10-20 | 2013-05-31 | Agency Science Tech & Res | Microfluidic system for trapping and detection of a biological entity in a sample |
| US10388403B2 (en) | 2010-01-19 | 2019-08-20 | Verinata Health, Inc. | Analyzing copy number variation in the detection of cancer |
| KR20130000396A (ko) * | 2010-03-04 | 2013-01-02 | 메사추세츠 인스티튜트 오브 테크놀로지 | 세포 검출 및 단리를 위한 마이크로유체 선별기 |
| EP2547795B1 (en) | 2010-03-16 | 2015-01-14 | Nanostring Technologies, Inc | Compositions and methods for the detection of genomic features |
| IT1399366B1 (it) | 2010-04-08 | 2013-04-16 | Weightpack S P A | Camma variabile, particolarmente per macchine per l'applicazione di tappi. |
| US8725422B2 (en) | 2010-10-13 | 2014-05-13 | Complete Genomics, Inc. | Methods for estimating genome-wide copy number variations |
| SG10201508373UA (en) | 2010-10-20 | 2015-11-27 | Bionano Genomics Inc | Systems and methods for assessing biomolecule characteristics |
| BR112013020220B1 (pt) | 2011-02-09 | 2020-03-17 | Natera, Inc. | Método para determinar o estado de ploidia de um cromossomo em um feto em gestação |
| WO2014014498A1 (en) | 2012-07-20 | 2014-01-23 | Verinata Health, Inc. | Detecting and classifying copy number variation in a fetal genome |
| KR101489568B1 (ko) * | 2011-06-29 | 2015-02-03 | 비지아이 헬스 서비스 코포레이션 리미티드 | 태아 유전학적 이상의 비침습성 검출 |
| US20130072386A1 (en) | 2011-09-08 | 2013-03-21 | Bionano Genomics, Inc. | Physical map construction of whole genome and pooled clone mapping in nanochannel array |
| US10424394B2 (en) | 2011-10-06 | 2019-09-24 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9367663B2 (en) | 2011-10-06 | 2016-06-14 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| JP6073902B2 (ja) | 2011-10-06 | 2017-02-01 | セクエノム， インコーポレイテッド | 遺伝的変異の非侵襲的評価のための方法およびプロセス |
| CA2850785C (en) | 2011-10-06 | 2022-12-13 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9984198B2 (en) | 2011-10-06 | 2018-05-29 | Sequenom, Inc. | Reducing sequence read count error in assessment of complex genetic variations |
| US8688388B2 (en) | 2011-10-11 | 2014-04-01 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| DK2766496T3 (en) | 2011-10-11 | 2017-05-15 | Sequenom Inc | METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS |
| CA2861856C (en) | 2012-01-20 | 2020-06-02 | Sequenom, Inc. | Diagnostic processes that factor experimental conditions |
| EP2844771A4 (en) | 2012-05-04 | 2015-12-02 | Complete Genomics Inc | METHOD FOR DETERMINING THE ABSOLUTE GENOME-WIDE COPY COUNTER CHANGES OF COMPLEX TUMORS |
| ES2902401T3 (es) | 2012-05-21 | 2022-03-28 | Sequenom Inc | Métodos y procesos para la evaluación no invasiva de variaciones genéticas |
| US10497461B2 (en) | 2012-06-22 | 2019-12-03 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9347127B2 (en) | 2012-07-16 | 2016-05-24 | Veeco Instruments, Inc. | Film deposition assisted by angular selective etch on a surface |
| US20130309666A1 (en) | 2013-01-25 | 2013-11-21 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| CN105143462A (zh) | 2013-02-05 | 2015-12-09 | 生物纳米基因有限公司 | 用于单分子分析的方法 |
| CN105229168B (zh) | 2013-02-20 | 2020-07-17 | 生物纳米基因有限公司 | 纳米流体中分子的表征 |
-
2014
- 2014-02-19 CN CN201480009730.6A patent/CN105229168B/zh active Active
- 2014-02-19 CA CA2901460A patent/CA2901460A1/en active Pending
- 2014-02-19 JP JP2015558929A patent/JP6542676B2/ja active Active
- 2014-02-19 US US14/768,422 patent/US9809855B2/en active Active
- 2014-02-19 EP EP14753475.4A patent/EP2959015B1/en active Active
- 2014-02-19 WO PCT/US2014/017226 patent/WO2014130589A1/en not_active Ceased
- 2014-02-19 AU AU2014219001A patent/AU2014219001A1/en not_active Abandoned
-
2017
- 2017-10-27 US US15/795,847 patent/US10669586B2/en active Active
-
2019
- 2019-06-13 JP JP2019110164A patent/JP6928032B2/ja active Active
-
2020
- 2020-05-29 US US16/887,679 patent/US11359244B2/en active Active
-
2022
- 2022-05-11 US US17/741,708 patent/US12275992B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2959015A1 (en) | 2015-12-30 |
| US20200362413A1 (en) | 2020-11-19 |
| US10669586B2 (en) | 2020-06-02 |
| JP6928032B2 (ja) | 2021-09-01 |
| US20220340973A1 (en) | 2022-10-27 |
| US20180223361A1 (en) | 2018-08-09 |
| JP2019205434A (ja) | 2019-12-05 |
| EP2959015B1 (en) | 2020-11-04 |
| CN105229168B (zh) | 2020-07-17 |
| US20160046992A1 (en) | 2016-02-18 |
| US9809855B2 (en) | 2017-11-07 |
| EP2959015A4 (en) | 2016-08-17 |
| AU2014219001A1 (en) | 2015-10-08 |
| HK1219511A1 (zh) | 2017-04-07 |
| US12275992B2 (en) | 2025-04-15 |
| JP2016510590A (ja) | 2016-04-11 |
| WO2014130589A1 (en) | 2014-08-28 |
| CN105229168A (zh) | 2016-01-06 |
| US11359244B2 (en) | 2022-06-14 |
| JP6542676B2 (ja) | 2019-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12275992B2 (en) | Characterization of molecules in nanofluidics | |
| EP2462245B1 (en) | Device and methods for epigenetic analysis | |
| US11773429B2 (en) | Reduction of bias in genomic coverage measurements | |
| RU2753883C2 (ru) | Набор зондов для анализа образцов днк и способы их использования | |
| JP2005527220A (ja) | 単一のポリマー分析を使用する方法および装置 | |
| US10844424B2 (en) | Reduction of bias in genomic coverage measurements | |
| Su et al. | Single-molecule counting of point mutations by transient DNA binding | |
| US20130337450A1 (en) | Detection of quantitative genetic differences | |
| Loh et al. | Electric single-molecule hybridization detector for short DNA fragments | |
| HK1219511B (zh) | 纳米流体中分子的表徵 | |
| US20170268049A1 (en) | Nucleic acid detection method | |
| HK1231128A1 (en) | Reduction of bias in genomic coverage measurements | |
| HK1231128B (zh) | 减小基因组覆盖测量中的偏差 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20190219 |
|
| EEER | Examination request |
Effective date: 20190219 |
|
| EEER | Examination request |
Effective date: 20190219 |
|
| EEER | Examination request |
Effective date: 20190219 |
|
| EEER | Examination request |
Effective date: 20190219 |
|
| EEER | Examination request |
Effective date: 20190219 |
|
| EEER | Examination request |
Effective date: 20190219 |